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Microphthalmia with linear skin defects syndrome 
or MLS (OMIM #309801) is an embryonically male-lethal 
X-linked condition characterized by microphthalmia and 
linear, erythematous dermatological lesions. There is, 
however, high inter- and intrafamilial variability. Until now, 
61 patients have been described of whom 11 cases were 
familial (Appendix 1) [1-41]. Of these 61 patients, ten were 
reported to have eye anomalies without skin lesions, and 
four presented with skin defects without eye anomalies. In 
most of the cases, the syndrome is caused by deletion of a 
region on chromosome band Xq22.2 containing three genes 
MID1, HCCS, and ARHGAP6 of which HCCS is the only 
gene entirely contained within this interval [42,43]. At first, 
ARHGAP6, which encodes a rho GTPase activating protein 
(GAP), was considered the most likely candidate gene [16]. 
However, Wimplinger et al. recently reported three patients 
with MLS with a de novo mutation in the HCCS gene, indi-
cating that HCCS is the causal gene for MLS [29,31]. This 
gene encodes a mitochondrial enzyme, the holocytochrome 
c synthase, which covalently links a heme group to the 
apoprotein of cytochrome c and c1, resulting in the forma-
tion of holocytochrome c and c1. Holocytochrome c plays 
an essential role in oxidative phosphorylation in the mito-
chondrial respiratory chain [44,45]. Here we report the first 
familial cases in which unilateral microphthalmia with linear 
skin defects in the mother and isolated microphthalmia in the 
daughter are caused by a microdeletion spanning the entire 
HCCS gene and part of ARHGAP6.
METHODS
Clinical examination: Informed consent was obtained from 
all subjects, including the grandparents following the Tenets 
of Helsinki. This study was approved by the ethics committee 
of Ghent University Hospital. The proband is a 12-year-old 
girl, while her mother is 45 (Figure 1). Both patients are 
affected with MLS and underwent a complete ophthalmo-
logical examination and extensive imaging, with anterior 
segment pictures, corneal topography and keratometry 
(Pentacam, Oculus, Wetzlar, Germany, and Nidek KM-500, 
Aichi, Japan), autofluorescence, infrared reflectance and red 
free images, as well as spectral-domain optical coherence 
tomography (HRA2 and Spectralis, Heidelberg Engineering, 
Heidelberg, Germany) in both, and electroretinography (Reti-
port, Roland Consult, Brandenburg an der Havel, Germany) 
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Purpose: Microphthalmia with linear skin defects syndrome (MLS or MIDAS, OMIM #309801) is a rare X-linked 
male-lethal disorder characterized by microphthalmia or other ocular anomalies and skin lesions limited to the face and 
neck. However, inter- and intrafamilial variability is high. Here we report a familial case of MLS.
Methods: A mother and daughter with MLS underwent a complete ophthalmological examination, and extensive imag-
ing, including anterior segment pictures, corneal topography and keratometry, autofluorescence, infrared reflectance and 
red free images, as well as spectral-domain optical coherence tomography. The mother also underwent full-field flash 
electroretinography. In addition, high-resolution array comparative genomic hybridization analysis was performed in 
both as well as in the maternal grandparents of the proband.
Results: Microphthalmia and retinal abnormalities were noted in the proband and the mother, whereas only the mother 
presented with scars of the typical neonatal linear skin defects. Array comparative genomic hybridization analysis 
revealed a 185–220 kb deletion on chromosome band Xp22.2 including the entire HCCS gene.
Conclusions: The identification of a deletion including HCCS led to the diagnosis of MLS in these patients. Retinal 
abnormalities can be part of the ocular manifestations of MLS.
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in the mother. In addition, a general medical examination, 
including blood pressures, cardiac and pulmonary ausculta-
tion, weight, height and head circumference measurements, 
was performed.
Cytogenetic and molecular analysis: Conventional karyo-
typing was performed with G-banding using standard 
procedures on short-term lymphocyte cultures. For array 
comparative genomic hybridization (CGH) analysis, DNA 
was isolated from the total blood using the QIAamp DNA 
Blood Mini Kit (Qiagen, Venlo, The Netherlands) according 
to the manufacturer’s instructions. Copy number profiling 
was performed on 180 K oligonucleotide arrays (Agilent 
Technologies, Diegem, Belgium) according to the manufac-
turer’s instructions with minor modifications as described 
[46].
X-inactivation assay: Examination of the methylation pattern 
at the androgen receptor (AR) locus was performed on 
genomic DNA isolated from blood leucocytes according to 
Allen et al. [47]. More specifically, analysis of a polymorphic 
CAG repeat in the first exon of the human androgen-receptor 
gene was used to determine the X-inactivation state. The 
methylation status of a specific restriction enzyme site in 
the proximity of the polymorphic CAG short tandem repeat 
correlates with X-chromosome inactivation [47].
Parental testing: Parental testing was performed on genomic 
DNA isolated from the total blood using the Powerplex 16 
System (Promega, Leiden, The Netherlands) according to the 
manufacturer’s instructions.
RESULTS
Phenotype: The proband shows esotropia, with microph-
thalmia of the right eye, which is predominantly due to a 
reduced anterior chamber depth (Appendix 2). The right 
eye also showed microcornea, with a normal aspect of the 
cornea in the superior quarter, but with posterior bulging 
and thinning of the cornea in the central and inferotemporal 
areas, combined with a reticular golden white stromal haze 
and endothelial abnormalities in a honeycomb pattern 
posterior to an undulating Descemet membrane, as well as 
patent intrastromal corneal blood vessels inferotemporally, 
continuous with ghost vessels more centrally (Figure 2). The 
iris stroma was slightly hypoplastic, most pronounced in the 
inferior and temporal area, with an anterior synechia at seven 
o’clock. Fundoscopy showed no gross abnormalities in the 
microphthalmic right eye. The left eye was entirely normal 
apart from cornea plana (Appendix 2).
The mother of the proband had her left eye enucle-
ated at an early age because of severe microphthalmia, to 
avoid consequent orbital hypoplasia, and has since worn an 
ocular prosthesis. The anterior segment of her right eye was 
normal, whereas fundoscopy, fluorescein angiography, and 
optical coherence tomography showed patches of outer retinal 
abnormalities with white dots and pigment epithelial altera-
tions temporal from the macula and into the whole periphery 
(Figure 3). Electroretinography showed subnormal overall 
retinal function with all amplitudes reduced to approximately 
three fifths of normal values, albeit without delayed peak 
times (Figure 3). Whereas the mother had scars in the neck 
area consequent upon neonatal skin lesions typical of MLS 
(Figure 3), the skin of the proband was entirely normal.
A general medical and cardiological examination was 
entirely normal in both patients. The mother completed higher 
education, whereas the daughter is successful in high school.
In keeping with the male lethality of the MLS, the mother 
of the proband had three additional healthy daughters, and 
suffered three spontaneous abortions in the first trimester of 
pregnancy (Figure 1). Although never proven, these might 
have been male fetuses or severely affected female fetuses.
Genotype: Conventional karyotyping revealed a normal 
female karyotype, 46,XX, in the proband and her mother. 
Subsequent array CGH analysis revealed submicroscopic 
deletion of 185–220 kb on chromosome band Xp22.2 in the 
proband and the mother. Neither the maternal grandmother 
nor the maternal grandfather of the proband carried the 
Xp22.2 deletion, indicating that the deletion arose de novo in 
the mother. Paternity testing confirmed that both grandpar-
ents are the biologic parents of the mother and that the mother 
is indeed the biologic mother of the proband.
The deleted region contains the entire HCCS gene and 
partially spans ARHGAP6 (Figure 4). The telomeric break-
point lies in the intergenic region between MID1 and HCCS. 
The centromeric breakpoint lies in ARHGAP6. This dele-
tion has not yet been reported by the Toronto Database of 
Genomic Variants. The data of the mother (Patient 255,415) 
Figure 1. Pedigree of family with microphthalmia with linear skin 
defects syndrome. Open circles represent healthy females, filled 
circles are affected females, squares are healthy males, and small 
filled circles represent spontaneous abortions in the first trimester 
of pregnancy; the sex of the fetuses of the latter was unknown.
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and the proband (Patient 255,414) were submitted to the 
DECIPHER database (Database of Chromosomal Imbalance 
and Phenotype in Humans using Ensembl Resources).
X-inactivation testing revealed complete skewing in 
the mother and the proband. The chromosome containing 
the deletion is likely the inactive one in the mother and the 
proband.
DISCUSSION
Most of the previously reported MLS cases are sporadic 
although a few families with multiple affected individuals 
have been reported [2,18,20,29,30]. Here we report on the first 
familial cases in which the deleted region spans the entire 
HCCS gene and part of the ARHGAP6 gene.
The proband reported here presents with unilateral 
microphthalmia without skin lesions, whereas the mother had 
scars from neonatal linear skin defects in the neck region. The 
pattern of ocular abnormalities seen in the microphthalmic 
right eye of the proband suggests the microphthalmia is due 
to the predominant involvement of the anterior segment of 
the eye (anterior microphthalmia). In addition, the central and 
inferotemporal opacities of the right cornea in the proband 
represent the mild end of the spectrum of corneal opaci-
fication, of which classic sclerocornea is the extreme end. 
Corneal opacification has been described in 15 patients, and 
sclerocornea in 17 patients reported with ocular involvement 
[3,6,11,15,19,24,29,30].
Figure 2. All images from the 
proband. A: Microphthalmic right 
eye and clinically normal left eye; 
notice esotropia and corneal opaci-
fication of the right eye. B: Right 
eye with corneal opacification in 
central and inferotemporal areas. 
C: Detail of inferotemporal area of 
right eye; notice patent peripheral 
corneal vessels (arrow) in area of 
reticular endothelial abnormalities 
and relative stromal opacification. 
D: Detail of central area of right 
eye; notice central corneal ghost 
vessels (arrow) in area of corneal 
opacification.
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Only four reports mention retinal abnormalities in MLS 
patients, varying from chorioretinopathy over abnormalities 
of the retinal pigment epithelium (RPE) and foveal hypoplasia 
in eyes that also show microphthalmia [7,19,21], as well as 
multiple patches of hypopigmentation of the RPE in an other-
wise normal eye [24]. Fundoscopy and fluorescein angiog-
raphy of the right eye of the mother of the proband, showed 
white, drusenoid deposits and linear RPE abnormalities with 
hyper- and hypopigmentation in the peripheral macula and 
midperipheral retina (Figure 3). These findings, combined 
with the reduced overall retinal function as measured with 
electroretinography (Figure 3), suggest that retinal abnor-
malities may be the only ocular manifestation of MLS in an 
otherwise normal eye.
Although the characteristics of MLS are microphthalmia 
and linear skin lesions, there is inter- and intrafamilial pheno-
typic variability. Ocular and skin anomalies are present in 
Figure 3. All images from the 
mother of the proband. A: Multiple 
erythematous scars in neck (two 
indicated by arrows); lesions had 
aspect of hemorrhaging incisions 
in the neonatal period. B and C: 
Fundus abnormalities with white, 
drusenoid deposits and reticular 
RPE abnormalities in the macula 
(B: Small and large arrow respec-
tively), and whole fundus of left eye 
(C), with reticular abnormalities 
with alternating hypo- and hyper-
pigmentation of retinal pigment 
epithelium (RPE). D: Hyper- and 
hypointense areas on fluorescein 
angiography in keeping with RPE 
abnormalities described under A. 
E: Full-field flash electroretinog-
raphy of the right eye (top traces); 
traces at bottom are from normal 
age-matched control for purposes 
of comparison. Notice overall 
reduction of retinal function for 
rod-specific, combined rod-cone, 
and cone-specific responses to 
about three-fifths of normal ampli-
tudes, without significant delay in 
responses. Retinal function is thus 
reduced in keeping with the reduced 
total surface area of the retina, 
but the remaining areas function 
normally, suggesting this is not 
progressive retinal degeneration.
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most of the reported patients (47/61). A small number do not 
present with ocular manifestations (4/61), and others do not 
have skin anomalies (11/61; Appendix 1). It has been proposed 
that X-inactivation may play a role in the phenotypic vari-
ability in affected female patients. In 16/21 of the analyzed 
female individuals with MLS, skewed X-inactivation of the 
abnormal X chromosome was detected (Appendix 1). As it 
is suggested that X-inactivation ratios may vary between 
different tissues within an individual [48,49], the inter- and 
intrafamilial phenotypic variability is probably caused by 
differing degrees of skewing. Morleo et al. hypothesized that 
a milder phenotype or the total absence of MLS clinical mani-
festations may be due to a totally skewed X-inactivation that 
forces preferential activation of the unaffected X [50]. Here 
complete skewing was noted in the mother and daughter on 
blood leukocytes for which the X chromosome containing the 
deletion is likely the inactive one [29,30,50,51]. The clinical 
manifestations in the daughter are less severe than in the 
mother. It is indeed likely that the severity of the phenotype is 
more related to the tissue-specific degree of X-inactivation of 
the X-chromosome with either a mutation in, or a deletion of 
HCCS, than the effect of the mutation on the protein product 
itself. Since the proband does not have skin lesions, and the 
scars resulting from the neonatal skin defects in the mother 
are minimal, the two were not diagnosed with MLS at first.
Interestingly, Wimplinger et al. reported a de novo 
loss-of-function mutation in HCCS in a female with bilateral 
microphthalmia and severe sclerocornea, suggesting that 
HCCS is a candidate gene for severe eye malformations [31].
To further unravel the role of HCCS in the development 
of the eye, more patients with severe eye malformations need 
to be screened, and functional studies are required. It will 
also be interesting to see whether the microphthalmia is more 
commonly of an anterior type in MLS.
The use of array CGH in our patients has proven to be 
useful as the 185–220 kb deletion in these patients would have 
never been detected with conventional karyotyping. Most of 
the previous cases had larger cytogenetically visible deletions 
or translocations. Recently, Balikova et al. highlighted the 
importance of array CGH in diagnostics for patients with 
congenital eye malformations [52]. Using this technique, the 
phenotypic spectrum associated with the deletion of HCCS 
can be further broadened. In conclusion, we report on a 
family with two cases of unilateral microphthalmia of whom 
only one showed scars of neonatal linear skin lesions with a 
185–220 kb microdeletion containing HCCS and ARHGAP6, 
supporting the hypothesis that HCCS is a candidate gene for 
severe eye malformations.
APPENDIX 1.
Overview of all patients reported with MLS. Familial 
cases are highlighted in bold. Patients reported in abstracts 
or patients for whom no aberration on the X-chromosome 
was detected were left out of this table. NA=not applicable, 
ND=not determined. To access the data, click or select the 
words “Appendix 1.” This will initiate the download of a pdf 
file.
APPENDIX 2.
Ocular measurements of proband and her mother and normal 
values for comparison. To access the data, click or select the 
words “Appendix 2.” This will initiate the download of a pdf 
file.
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